Carlen A Yuen
Overview
Explore the profile of Carlen A Yuen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Himstead A, Chen J, Chu E, Perez-Rosendahl M, Zheng M, Mathew S, et al.
Biomedicines
. 2025 Jan;
13(1).
PMID: 39857783
: Anaplastic oligodendrogliomas (AOs) are central nervous system (CNS) World Health Organization (WHO) grade 3 gliomas characterized by isocitrate dehydrogenase (IDH) mutation (m)IDH and 1p/19q codeletion. AOs are typically treated...
2.
Yuen C, Bao S, Kong X, Terry M, Himstead A, Zheng M, et al.
Biomedicines
. 2024 Sep;
12(9).
PMID: 39335555
The World Health Organization's (WHO) classification of central nervous system (CNS) tumors is continually being refined to improve the existing diagnostic criteria for high-grade gliomas (HGGs), including glioblastoma. In 2021,...
3.
Yuen C, Bao S, Kong X
Biomark Med
. 2024 Jul;
18(9):431-439.
PMID: 39007837
Leptomeningeal metastasis (LM) is a devastating complication of malignancy. Diagnosis relies on both contrast enhancement on imaging and malignant cells in cerebral spinal fluid cytology. Though early detection and prompt...
4.
Yuen C, Bao S, Pekmezci M, Mo F, Kong X
Immunotherapy
. 2024 Jun;
16(12):803-811.
PMID: 38889068
Persons living with human immunodeficiency virus (PLWH) carry increased risk for developing malignancies, including glioblastoma. Despite extensive investigations, both human immunodeficiency virus (HIV) and glioblastoma are incurable. Treatment for a...
5.
Yuen C, Pekmezci M, Bao S, Kong X
CNS Oncol
. 2024 Jun;
13(1):2351789.
PMID: 38864820
Glioblastoma is the most common malignant primary brain tumor. Despite its infiltrative nature, extra-cranial glioblastoma metastases are rare. We present a case of a 63-year-old woman with metastatic glioblastoma in...
6.
Yuen C, Bao S, Aung M, Shishodia R, Kong X
Per Med
. 2024 Jan;
21(2):71-78.
PMID: 38275171
Erdheim-Chester disease (ECD) is an exceedingly rare non-Langerhans cell CD68 CD1a S100 histiocytic multi-organ disease. Diagnosis of ECD is often delayed due to non-specific radiographic findings and heterogeneous lesional tissue....
7.
Yuen C, Hsu J, Van Besien K, Reshef R, Iwamoto F, Haggiagi A, et al.
J Immunother
. 2022 Apr;
45(5):254-262.
PMID: 35404315
Secondary central nervous system lymphoma (SCNSL) is associated with poor prognosis and new therapeutic approaches are needed. The pivotal trial that led to US Food and Drug Administration (FDA) approval...
8.
Yuen C, Barbaro M, Haggiagi A
Curr Oncol Rep
. 2022 Feb;
24(3):387.
PMID: 35199296
No abstract available.
9.
Yuen C, Barbaro M, Haggiagi A
Curr Oncol Rep
. 2022 Feb;
24(3):325-334.
PMID: 35122621
Purpose Of Review: Elderly patients with newly diagnosed glioblastoma (eGBM) carry a worse prognosis compared with their younger counterparts. eGBM garners special attention due to the unique challenges, including increased...
10.
Xie T, Yuen C, Kang W, Padmanaban M, Hain T, Nichols J
Front Neurol
. 2021 Oct;
12:736784.
PMID: 34650511
It is an unmet need to estimate survival duration for patients with progressive supranuclear palsy (PSP). The objective of this study was to identify factors associated with the survival duration...